Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 140

1.

Do Work Condition Interventions Affect Quality and Errors in Primary Care? Results from the Healthy Work Place Study.

Linzer M, Poplau S, Brown R, Grossman E, Varkey A, Yale S, Williams ES, Hicks L, Wallock J, Kohnhorst D, Barbouche M.

J Gen Intern Med. 2017 Jan;32(1):56-61. doi: 10.1007/s11606-016-3856-2. Epub 2016 Sep 9.

PMID:
27612486
2.

Thromboembolic complications following a first isolated episode of superficial vein thrombosis: a cross-sectional retrospective study.

Bell LN, Berg RL, Schmelzer JR, Liang H, Mazza JJ, Kanth R, Bray CL, Zaldivar CB, Yale SH.

J Thromb Thrombolysis. 2017 Jan;43(1):31-37. doi: 10.1007/s11239-016-1414-8.

PMID:
27565478
3.

A SMAD4 mutation indicative of juvenile polyposis syndrome in a family previously diagnosed with Menetrier's disease.

Burmester JK, Bell LN, Cross D, Meyer P, Yale SH.

Dig Liver Dis. 2016 Oct;48(10):1255-9. doi: 10.1016/j.dld.2016.06.010. Epub 2016 Jun 17.

PMID:
27375208
4.

Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide Antimicrobials.

Reinhart JM, Motsinger-Reif A, Dickey A, Yale S, Trepanier LA.

PLoS One. 2016 Jun 7;11(6):e0156000. doi: 10.1371/journal.pone.0156000. eCollection 2016.

5.

Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.

Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, Yale SH, Go AS.

Med Care. 2016 Feb 25. [Epub ahead of print]

PMID:
26918401
6.

A Review of Clinical Signs Related to Ecchymosis.

Epperla N, Mazza JJ, Yale SH.

WMJ. 2015 Apr;114(2):61-5. Review.

7.

Variation in Definitions of Immobility in Pharmacological Thromboprophylaxis Clinical Trials in Medical Inpatients.

Ye F, Bell LN, Mazza J, Lee A, Yale SH.

Clin Appl Thromb Hemost. 2016 Jan 1:1076029616677802. doi: 10.1177/1076029616677802. [Epub ahead of print]

PMID:
28301904
8.

Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Shukla SK, Cook D, Meyer J, Vernon SD, Le T, Clevidence D, Robertson CE, Schrodi SJ, Yale S, Frank DN.

PLoS One. 2015 Dec 18;10(12):e0145453. doi: 10.1371/journal.pone.0145453. eCollection 2015.

9.

Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.

Fang MC, Fan D, Sung SH, Witt DM, Yale SH, Steinhubl SR, Go AS.

JAMA Intern Med. 2015 Jun;175(6):1060-2. doi: 10.1001/jamainternmed.2015.0936. No abstract available.

10.

Factors that affect rate of INR decline after warfarin discontinuation.

Burmester JK, Berg RL, Schmelzer JR, Mazza JJ, Yale SH.

WMJ. 2015 Feb;114(1):16-20.

11.

Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy.

Epperla N, Medina-Flores R, Mazza JJ, Yale SH.

WMJ. 2014 Dec;113(6):242-5.

12.

A Cluster Randomized Trial of Interventions to Improve Work Conditions and Clinician Burnout in Primary Care: Results from the Healthy Work Place (HWP) Study.

Linzer M, Poplau S, Grossman E, Varkey A, Yale S, Williams E, Hicks L, Brown RL, Wallock J, Kohnhorst D, Barbouche M.

J Gen Intern Med. 2015 Aug;30(8):1105-11. doi: 10.1007/s11606-015-3235-4. Epub 2015 Feb 28.

13.

Risk factors for recurrent spontaneous epistaxis.

Abrich V, Brozek A, Boyle TR, Chyou PH, Yale SH.

Mayo Clin Proc. 2014 Dec;89(12):1636-43. doi: 10.1016/j.mayocp.2014.09.009. Epub 2014 Nov 6.

PMID:
25458126
14.

Reinitiating warfarin: relationships between dose and selected patient, clinical and hospital measures.

Leonhard LG, Berg RL, Burmester JK, Mazza JJ, Schmelzer JR, Yale SH.

Clin Med Res. 2015 Mar;13(1):1-6. doi: 10.3121/cmr.2014.1208. Epub 2014 Jun 4.

15.

Drinking water systems, hydrology, and childhood gastrointestinal illness in Central and Northern Wisconsin.

Uejio CK, Yale SH, Malecki K, Borchardt MA, Anderson HA, Patz JA.

Am J Public Health. 2014 Apr;104(4):639-46. doi: 10.2105/AJPH.2013.301659. Epub 2014 Feb 13.

16.

Association between blood glucose level and outcomes in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease.

Kasirye Y, Simpson M, Mamillapalli CK, Epperla N, Liang H, Yale SH.

WMJ. 2013 Dec;112(6):244-9; quiz 250.

17.

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators..

N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19.

18.

Learning to predict post-hospitalization VTE risk from EHR data.

Kawaler E, Cobian A, Peissig P, Cross D, Yale S, Craven M.

AMIA Annu Symp Proc. 2012;2012:436-45. Epub 2012 Nov 3.

19.

Anti-phospholipid antibodies in patients undergoing total joint replacement surgery.

Simpson M, Sanfelippo MJ, Onitilo AA, Burmester JK, Hocking W, Yale SH, Mazza JJ.

Thrombosis. 2012;2012:142615. doi: 10.1155/2012/142615. Epub 2012 Oct 31.

20.

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.

Sacco JC, Abouraya M, Motsinger-Reif A, Yale SH, McCarty CA, Trepanier LA.

Pharmacogenet Genomics. 2012 Oct;22(10):733-40. doi: 10.1097/FPC.0b013e328357a735.

Supplemental Content

Loading ...
Support Center